Haridha Shivram

机构：Acentech (United States) · ORCID：0000-0001-5897-8288

发表论文 66 篇 · 总被引 1781 次 · h-index 13

代表论文

• Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant (2021 · Cell · 被引 543)
• Species- and site-specific genome editing in complex bacterial communities (2021 · Nature Microbiology · 被引 298)
• Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation (2021 · medRxiv · 被引 248)
• Controlling and enhancing CRISPR systems (2020 · Nature Chemical Biology · 被引 198)
• Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19 (2023 · iScience · 被引 14)
• A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling (2023 · iScience · 被引 12)